Skip to main content
SpringerLink
Log in

Detection of local residual tumor after laryngeal cancer treatment using FDG-PET

  • Original Articles
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective: Fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET) is sometimes used as a means of follow-up after diagnosis and treatment of cancers of the head and neck region. The present study was undertaken to evaluate the ability of FDG-PET to detect local residual tumor after treatment of laryngeal cancer.Methods: Thirty-six patients with laryngeal cancer underwent FDG-PET before and after initial treatment. Of these patients, 20 received FDG-PET before treatment and 28 received it after treatment. The relationship between standardized uptake values (SUV) and the presence or absence of local residual tumor was investigated by setting the cut-off value of the SUV using the receiver operating characteristics (ROC) curve.Results: When the pre-treatment SUV threshold for laryngeal cancer was set at 7.20, the detection of local residual tumor after treatment using FDG-PET had a sensitivity of 77.78%, specificity of 81.82%, false positive rate of 18.18%, false negative rate of 22.22%, accuracy of 80% and a p value of 0.02. When the post-treatment SUV threshold for the larynx was set at 3.35, the test had a sensitivity of 93.75%, specificity of 91.67%, false positive rate of 8.33%, false negative rate of 6.25%, accuracy of 92.86% and a p value of 0.0001.Conclusions: FDG-PET was found to be useful for determining the presence of local residual tumor after treatment of laryngeal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Van den Abbeele AD, Badawi RD. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs).Eur J Cancer 2002; 38 (Suppl 5): S60–65.

    Google Scholar 

  2. Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, et al. Prospective comparison of18F-FDG PET with conventional imaging modalities (MRI, CT, and67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.J Nucl Med 2003; 44: 198–206.

    PubMed  Google Scholar 

  3. Sakamoto H, Nakai Y, Ohashi Y, Matsuda M, Sakashita T, Nasako Y, et al. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.Acta Otolaryngol 1998; 538 (Suppl): 254–260.

    Article  CAS  Google Scholar 

  4. Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.Eur J Nucl Med Mol Imaging 2004; 31: 590–595.

    Article  PubMed  Google Scholar 

  5. Kubota K. From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology.Ann Nucl Med 2001; 15: 471–486.

    Article  PubMed  CAS  Google Scholar 

  6. Kelloff GJ, Hoffman JM, Johnson B, Scher HI, Siegel BA, Cheng EY, et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.Clin Cancer Res 2005; 11: 2785–2808.

    Article  PubMed  CAS  Google Scholar 

  7. Strauss LG, Conti PS. The applications of PET in clinical oncology.J Nucl Med 1991; 32: 623–648.

    PubMed  CAS  Google Scholar 

  8. Strauss LG. Positron Emission Tomography: Current Role for Diagnosis and Therapy Monitoring in Oncology.Oncologist 1997; 2: 381–388.

    PubMed  Google Scholar 

  9. Kawabe J, Okamura T, Shakudo M, Koyama K, Sakamoto H, Ohachi Y, et al. Physiological FDG uptake in the palatine tonsils.Ann Nucl Med 2001; 15: 297–300.

    Article  PubMed  CAS  Google Scholar 

  10. Schwartz DL, Rajendran J, Yueh B, Coltrera MD, Leblanc M, Eary J, et al. FDG-PET prediction of head and neck squamous cell cancer outcomes.Arch Otolaryngol Head Neck Surg 2004; 130: 1361–1367.

    Article  PubMed  Google Scholar 

  11. Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M. FDG-PET. A possible prognostic factor in head and neck cancer.Br J Cancer 2002; 86: 512–516.

    Article  PubMed  CAS  Google Scholar 

  12. Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, et al. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.Eur J Nucl Med Mol Imaging 2003; 30: 63–71.

    Article  PubMed  CAS  Google Scholar 

  13. Allal AS, Dulguerov P, Allaoua M, Haenggeli CA, El-Ghaziel A, Lehmann W, et al. Standardized uptake value of 2-[(18)F]fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy.J Clin Oncol 2002; 20: 1398–1404.

    Article  PubMed  CAS  Google Scholar 

  14. Minn H, Lapela M, Klemi PJ, Grenman R, Leskinen S, Lindholm P, et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.J Nucl Med.1997; 38: 1907–1911.

    PubMed  CAS  Google Scholar 

  15. Brun E, Kjellen E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.Head Neck 2002; 24: 127–135.

    Article  PubMed  Google Scholar 

  16. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer.Head Neck 2001; 23: 933–941.

    Article  PubMed  CAS  Google Scholar 

  17. Haenggeli CA, Dulguerov P, Slosman D, Becker M, Bang P, Allal A, et al. Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma.Schweiz Med Wochenschr 2000; 116 (Suppl): 8S-11S.

    CAS  Google Scholar 

  18. Cheon GJ, Chung JK, So Y, Choi JY, Kim BT, Jeong JM, et al. Diagnostic Accuracy of F-18 FDG-PET in the Assessment of Posttherapeutic Recurrence of Head and Neck Cancer.Clin Positron Imaging 1999; 2: 197–204.

    Article  PubMed  Google Scholar 

  19. Conessa C, Herve S, Foehrenbach H, Poncet JL. FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.Ann Otol Rhinol Laryngol 2004; 113: 628–635.

    PubMed  Google Scholar 

  20. Greven KM, Williams DW 3rd, Keyes JW Jr, McGuirt WF, Watson NE Jr, Case LD. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer?Cancer J Sci Am 1997; 3: 353–357.

    PubMed  CAS  Google Scholar 

  21. McGuirt WF, Greven K, Williams D 3rd, Keyes JW Jr, Watson N, Cappellari JO. PET scanning in head and neck oncology: a review.Head Neck 1998; 20: 208–215.

    Article  PubMed  CAS  Google Scholar 

  22. Wong RJ, Lin DT, Schoder H, Patel SG, Gonen M, Wolden S, et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.J Clin Oncol 2002; 20: 4199–4208.

    Article  PubMed  CAS  Google Scholar 

  23. Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation.Arch Otolaryngol Head Neck Surg 2004; 130: 875–879.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Graduate School of Medicine, Osaka City University, 1-4-3 Asahimachi Abeno-ku, 545-8585, Osaka, Japan

    Ai Oe M.D., Joji Kawabe, Kenji Torii, Etsushi Kawamura, Jin Kotani, Takehiro Hayashi, Hiroko Kurooka, Hiroyuki Tsushima & Susumu Shiomi

  2. Department of Gastroenterology, Graduate School of Medicine, Osaka City University, 1-4-3 Ashimachi, Abeno-ku, 545-8585, Osaka, Japan

    Chikako Tsumoto

  3. Department of Radiology, Graduate School of Medicine, Osaka City University, 1-4-3 Asahimachi, Abeno-ku, 545-8585, Osaka, Japan

    Shigeaki Higashiyama

  4. Department of Otorhinolaryngology, Graduate School of Medicine, Osaka City University, 1-4-3 Asahimachi, Abeno-ku, 545-8585, Osaka, Japan

    Makoto Kusuki & Hideo Yamane

Authors
  1. Ai Oe M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joji Kawabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenji Torii
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Etsushi Kawamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jin Kotani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takehiro Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiroko Kurooka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chikako Tsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shigeaki Higashiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Makoto Kusuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hiroyuki Tsushima
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hideo Yamane
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Susumu Shiomi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oe, A., Kawabe, J., Torii, K. et al. Detection of local residual tumor after laryngeal cancer treatment using FDG-PET. Ann Nucl Med 21, 9–13 (2007). https://doi.org/10.1007/BF03033994

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033994

Key words

Search

Navigation